Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Conditions
Interventions
- DRUG: doxorubicin hydrochloride
- DRUG: topotecan hydrochloride
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators